Ordering
Available Variants5 mg
CHA.81321-5mg
Price
€79.60
Available – Dispatch in 14 days
25 mg
CHA.81321-25mg
Price
€295.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.81321-5mg | €79.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.81321-25mg | €295.20 |
≥95% (HPLC), powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C10H15N3O5 |
|---|---|
| CAS Number | 20724-73-6 |
| Molecular Weight | 257.24 |
| NACRES | NA.77 |
| PubChem Substance ID | 329817997 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD02682947 |
| Assay | ≥95% (HPLC) |
| Form | powder |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H315,H319,H335 |
| pcodes | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
2′-C-Methylcytidine, with the CAS registry number 20724-73-6, is a nucleoside analog that has garnered significant attention in the realm of antiviral research. This compound is characterized by the presence of a methyl group at the 2′ position of the cytidine sugar moiety, which distinguishes it from its naturally occurring counterpart. The modification confers unique properties to the molecule, including altered base pairing and stacking interactions, which can influence its incorporation into nucleic acids and subsequent biological effects. As a result, 2′-C-Methylcytidine has been investigated for its potential to inhibit the replication of various viruses, with studies exploring its mechanism of action and potential therapeutic applications. Further research is needed to fully elucidate the properties and potential uses of this intriguing compound. Its antiviral activity makes it a valuable candidate for pharmaceutical development.
